-
Mattress shopping really makes me want to take a nap
Last week, my wife, Wendy, and I finally got around to starting the process of […]
-
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy
– ENTR-601-44 was well-tolerated in healthy volunteers with no serious adverse events, no drug-related adverse […]
-
REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients
Company to begin enrollment of patients aged 1-3 years Expects data from younger cohort to be […]
-
Genethon’s Duchenne Muscular Dystrophy Gene Therapy GNT0004 Produces Expression of Microdystrophin in Phase 1/2/3 Trial
Genethon reported positive results from its AAV-microdystrophin treatment trial in Europe. The three participants receiving […]
-
REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include New Cohort of Younger Patients
REGENXBIO has announced it initiated enrollment in a new cohort of patients ages 1-3 in […]
-
Elevidys DMD gene therapy now FDA-approved for ages 4 and older
The U.S. Food and Drug Administration (FDA) has expanded its approval of Elevidys (delandistrogene moxeparvovec-rokl), […]
-
FSHD treatment del-brax (formerly AOC 1020) aids muscle function
AOC 1020, an investigational treatment by Avidity Biosciences that’s now called delpacibart braxlosiran, or del-brax, […]
-
La Organización Mundial Sin Fines de Lucro CureDuchenne Llevará a Cabo Seminarios Web Informativos Tras la Ampliación de la Etiqueta de ELEVIDYS, la Terapia Génica de Sarepta Therapeutics, por la FDA
NEWPORT BEACH, California, 21 de junio de 2024 /PRNewswire-HISPANIC PR WIRE/ — CureDuchenne, una organización mundial sin fines […]
-
Finding a balance between fighting for healthcare and celebrating wins
Recently, our family had terrific reasons to celebrate. I have three sons with Duchenne muscular […]
-
Global Nonprofit CureDuchenne to Host Informational Webinars Following FDA Label Expansion of Sarepta Therapeutics’ Gene Therapy, ELEVIDYS
NEWPORT BEACH, Calif., June 20, 2024 /PRNewswire/ — CureDuchenne, a global nonprofit committed to finding and funding a cure […]
